Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution
Menu

Contact Us
If you have any questions or feedback please contact us.
 Back to Profile

John Corboy

Concepts (369)

Concepts are derived automatically from a person's publications.

Cloud
Categories
Timeline
Details
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Multiple Sclerosis
47
2024
376
8.180
 Why?
Multiple Sclerosis, Relapsing-Remitting
14
2024
69
3.050
 Why?
Neurology
10
2018
84
2.460
 Why?
Immunosuppressive Agents
10
2024
646
1.790
 Why?
Immunologic Factors
11
2020
220
1.670
 Why?
Neuromyelitis Optica
4
2023
115
1.220
 Why?
Natalizumab
11
2021
46
0.990
 Why?
Recurrence
7
2024
935
0.780
 Why?
Diagnostic Errors
2
2017
149
0.760
 Why?
Internship and Residency
5
2011
926
0.750
 Why?
Drug Substitution
2
2019
46
0.680
 Why?
Fingolimod Hydrochloride
5
2020
29
0.670
 Why?
Rituximab
4
2020
150
0.640
 Why?
Brain
14
2021
2371
0.640
 Why?
Data Collection
4
2011
620
0.630
 Why?
Dementia, Vascular
3
2009
16
0.610
 Why?
Drug Monitoring
1
2019
184
0.590
 Why?
Medication Adherence
2
2019
536
0.550
 Why?
Early Medical Intervention
1
2017
52
0.550
 Why?
Early Diagnosis
2
2017
217
0.540
 Why?
Physicians
4
2016
772
0.530
 Why?
Glatiramer Acetate
6
2019
20
0.520
 Why?
Calcinosis
2
2009
242
0.500
 Why?
Antibodies, Monoclonal, Humanized
8
2023
663
0.500
 Why?
Postural Balance
3
2018
183
0.500
 Why?
Humans
79
2024
114674
0.490
 Why?
Magnetic Resonance Imaging
23
2023
3046
0.470
 Why?
Fatigue
3
2018
294
0.420
 Why?
Dimethyl Fumarate
3
2020
10
0.390
 Why?
Immunoglobulin G
4
2023
770
0.380
 Why?
Practice Guidelines as Topic
1
2018
1394
0.360
 Why?
Multiple Sclerosis, Chronic Progressive
3
2020
25
0.350
 Why?
Withholding Treatment
2
2021
68
0.340
 Why?
Middle Aged
37
2021
26735
0.330
 Why?
Psychiatry
2
2009
154
0.320
 Why?
Adult
41
2023
30546
0.310
 Why?
Cysts
1
2009
93
0.300
 Why?
Education, Medical
1
2011
215
0.300
 Why?
Demyelinating Diseases
4
2019
75
0.300
 Why?
Autoantibodies
3
2023
1346
0.290
 Why?
Certification
1
2008
89
0.290
 Why?
Clinical Trials as Topic
3
2016
932
0.280
 Why?
Education
2
2007
95
0.280
 Why?
Central Nervous System Cysts
1
2006
11
0.270
 Why?
Cerebral Arteries
1
2006
55
0.270
 Why?
Myelin-Oligodendrocyte Glycoprotein
2
2023
44
0.260
 Why?
Single-Blind Method
3
2023
258
0.260
 Why?
Societies, Medical
4
2019
663
0.260
 Why?
Cerebrovascular Disorders
1
2006
82
0.260
 Why?
Treatment Outcome
12
2023
9088
0.260
 Why?
Female
46
2023
59499
0.260
 Why?
DNA, Viral
2
1998
350
0.250
 Why?
HIV Long Terminal Repeat
2
1997
8
0.250
 Why?
Databases, Factual
3
2016
1125
0.250
 Why?
Male
36
2023
55589
0.240
 Why?
Double-Blind Method
4
2023
1660
0.240
 Why?
Drug Industry
2
2016
103
0.230
 Why?
Conflict of Interest
2
2016
119
0.220
 Why?
Encephalomyelitis, Autoimmune, Experimental
1
2023
51
0.210
 Why?
Quality of Health Care
2
2017
573
0.200
 Why?
B-Lymphocytes
5
2023
766
0.200
 Why?
Mental Disorders
2
2007
892
0.200
 Why?
Brain Neoplasms
4
2016
979
0.200
 Why?
Lymphoma
2
2005
177
0.190
 Why?
Interferon beta-1a
2
2019
12
0.190
 Why?
Neuroimaging
1
2023
249
0.190
 Why?
Central Nervous System Neoplasms
2
2005
126
0.190
 Why?
Education, Medical, Continuing
2
2015
117
0.180
 Why?
Disease Progression
4
2021
2380
0.180
 Why?
Lymphopenia
1
2020
49
0.180
 Why?
Agammaglobulinemia
1
2020
30
0.170
 Why?
Referral and Consultation
1
2005
634
0.170
 Why?
Interferon-gamma
1
2023
719
0.170
 Why?
Neutropenia
1
2020
125
0.170
 Why?
Serum Sickness
1
2019
7
0.170
 Why?
Indans
1
2019
9
0.170
 Why?
Oxadiazoles
1
2019
32
0.170
 Why?
Diagnosis, Differential
4
2023
1342
0.160
 Why?
Educational Measurement
3
2015
243
0.150
 Why?
Adjuvants, Immunologic
3
2015
206
0.150
 Why?
Salvage Therapy
1
2019
127
0.150
 Why?
Lymphoma, AIDS-Related
1
1998
13
0.150
 Why?
Physician-Patient Relations
2
2016
462
0.150
 Why?
Hematopoietic Stem Cell Transplantation
2
2019
520
0.150
 Why?
Drug-Related Side Effects and Adverse Reactions
1
2020
238
0.150
 Why?
Herpesvirus 8, Human
1
1998
61
0.150
 Why?
Eye Movements
1
2018
53
0.150
 Why?
AIDS Dementia Complex
1
1997
50
0.140
 Why?
Central Nervous System
2
2005
235
0.140
 Why?
Diffuse Cerebral Sclerosis of Schilder
1
2017
4
0.140
 Why?
Patient Selection
2
2015
641
0.140
 Why?
Sarcoma, Kaposi
1
1998
68
0.140
 Why?
Herpesvirus 4, Human
1
2018
125
0.140
 Why?
HIV Seropositivity
1
1998
109
0.140
 Why?
Young Adult
6
2023
10466
0.140
 Why?
Neurologists
1
2016
18
0.140
 Why?
Herpesviridae Infections
1
1998
138
0.140
 Why?
Aged
8
2023
19073
0.130
 Why?
Cost-Benefit Analysis
2
2016
544
0.130
 Why?
Costs and Cost Analysis
1
2017
196
0.130
 Why?
Estriol
1
2015
5
0.130
 Why?
T-Lymphocytes
1
2023
1737
0.130
 Why?
Dizziness
2
2018
70
0.130
 Why?
Verbal Learning
2
2013
63
0.120
 Why?
Corpus Callosum
2
2006
57
0.120
 Why?
Follow-Up Studies
6
2020
4411
0.120
 Why?
Diffusion Magnetic Resonance Imaging
2
2006
83
0.120
 Why?
Trust
1
2016
105
0.120
 Why?
Retrospective Studies
9
2020
12549
0.120
 Why?
Ethics, Medical
1
2015
70
0.120
 Why?
Mesenchymal Stem Cell Transplantation
1
2014
37
0.120
 Why?
Exercise Therapy
1
2018
352
0.110
 Why?
Insurance, Health
1
2016
244
0.110
 Why?
Medication Reconciliation
1
2013
25
0.110
 Why?
CD40 Antigens
1
2014
82
0.110
 Why?
T-Lymphocytes, Helper-Inducer
1
2014
127
0.110
 Why?
Anti-Inflammatory Agents
2
2006
447
0.110
 Why?
JC Virus
1
2013
23
0.110
 Why?
Population Surveillance
1
2016
392
0.110
 Why?
Glioma
1
2016
294
0.100
 Why?
Sensation Disorders
1
2012
31
0.100
 Why?
Memory Disorders
1
2013
155
0.100
 Why?
Immune Reconstitution Inflammatory Syndrome
1
2012
18
0.100
 Why?
Immunoglobulin Heavy Chains
3
2007
72
0.100
 Why?
Leukoencephalopathy, Progressive Multifocal
1
2012
38
0.100
 Why?
Lymphoma, T-Cell, Peripheral
1
2012
15
0.100
 Why?
Optic Nerve
2
2005
65
0.100
 Why?
T-Lymphocyte Subsets
1
2014
383
0.100
 Why?
Quality of Life
3
2021
2353
0.090
 Why?
Gadolinium
4
2018
73
0.090
 Why?
Learning
1
2015
350
0.090
 Why?
Biomarkers
3
2014
3408
0.090
 Why?
Self-Assessment
1
2011
60
0.090
 Why?
Academies and Institutes
1
2011
44
0.090
 Why?
Nervous System Diseases
1
2013
255
0.090
 Why?
Nerve Regeneration
1
2010
50
0.090
 Why?
Fatal Outcome
3
2006
284
0.090
 Why?
Diagnostic Tests, Routine
1
2011
87
0.090
 Why?
Antigens, CD19
3
2007
91
0.090
 Why?
Severity of Illness Index
3
2014
2539
0.090
 Why?
Leukocytosis
1
2010
34
0.090
 Why?
Exercise Test
1
2012
544
0.090
 Why?
Cranial Nerve Neoplasms
1
1989
6
0.080
 Why?
Hemangioma, Cavernous
1
1989
14
0.080
 Why?
United States
7
2019
12182
0.080
 Why?
Optic Chiasm
1
1989
18
0.080
 Why?
Disease Management
1
2013
560
0.080
 Why?
Central Nervous System Infections
1
2010
36
0.080
 Why?
Guidelines as Topic
1
2011
243
0.080
 Why?
Spinal Cord
3
2023
347
0.080
 Why?
Physical Therapy Modalities
1
2011
265
0.080
 Why?
Neuroprotective Agents
1
2009
104
0.080
 Why?
Practice Patterns, Physicians'
1
2016
1177
0.080
 Why?
Workload
1
2009
132
0.070
 Why?
Antibodies, Monoclonal
2
2011
1262
0.070
 Why?
Hospital-Physician Relations
1
2007
2
0.070
 Why?
Neuropsychological Tests
2
2013
927
0.070
 Why?
Immunoglobulin Variable Region
2
2004
72
0.070
 Why?
HIV-1
1
1992
768
0.070
 Why?
Headache Disorders
1
2006
12
0.070
 Why?
Vasculitis, Central Nervous System
1
2006
17
0.070
 Why?
Nerve Fibers, Myelinated
1
2006
41
0.070
 Why?
Huntington Disease
1
2007
39
0.070
 Why?
Contrast Media
3
2018
345
0.070
 Why?
Medical Records
1
2007
153
0.070
 Why?
Glial Fibrillary Acidic Protein
1
2006
79
0.070
 Why?
Syndrome
2
2023
333
0.070
 Why?
International Classification of Diseases
1
2007
116
0.070
 Why?
Methylprednisolone
1
2006
81
0.070
 Why?
Antibody Formation
1
2007
266
0.070
 Why?
Intracranial Hemorrhages
1
2006
76
0.070
 Why?
Fellowships and Scholarships
1
2009
227
0.060
 Why?
Herpes Zoster
1
2010
331
0.060
 Why?
Aquaporin 4
1
2006
87
0.060
 Why?
Surveys and Questionnaires
4
2016
4622
0.060
 Why?
Canada
2
2019
322
0.060
 Why?
DNA Mutational Analysis
1
2006
372
0.060
 Why?
RNA, Messenger
1
1992
2553
0.060
 Why?
Patient Compliance
1
2009
525
0.060
 Why?
Health Care Surveys
1
2007
539
0.060
 Why?
Teaching
1
2007
213
0.060
 Why?
Erythrocytes
1
2010
591
0.060
 Why?
Cognition Disorders
1
2009
476
0.060
 Why?
Affect
1
2007
246
0.060
 Why?
Analysis of Variance
3
2015
1226
0.060
 Why?
Neurologic Examination
1
2005
114
0.060
 Why?
Program Evaluation
1
2009
822
0.060
 Why?
Neutrophils
1
2010
1176
0.060
 Why?
Central Nervous System Diseases
1
2005
61
0.060
 Why?
Faculty, Medical
1
2006
228
0.060
 Why?
Simvastatin
1
2004
59
0.060
 Why?
Ophthalmoplegia
1
2003
8
0.060
 Why?
Proteoglycans
1
2004
107
0.060
 Why?
Diagnostic Techniques, Ophthalmological
1
2003
36
0.050
 Why?
Adolescent
7
2021
17841
0.050
 Why?
B-Lymphocyte Subsets
1
2003
68
0.050
 Why?
Cyclophosphamide
1
2003
217
0.050
 Why?
Students, Medical
1
2006
262
0.050
 Why?
Anticoagulants
1
2006
550
0.050
 Why?
Radiography
1
2005
812
0.050
 Why?
Cross-Sectional Studies
1
2012
4408
0.050
 Why?
Academic Medical Centers
1
2005
411
0.050
 Why?
Dementia
1
2005
187
0.050
 Why?
Membrane Glycoproteins
1
2004
430
0.050
 Why?
Infusions, Intravenous
1
2023
371
0.050
 Why?
Lymphoma, B-Cell
2
2005
86
0.050
 Why?
Patient Outcome Assessment
1
2023
122
0.050
 Why?
Clinical Competence
1
2008
893
0.050
 Why?
Peptides
3
2013
848
0.050
 Why?
Time Factors
4
2018
6115
0.050
 Why?
Pain
1
2007
705
0.050
 Why?
Schools, Medical
1
2002
120
0.050
 Why?
Disability Evaluation
2
2014
271
0.050
 Why?
Molecular Sequence Data
3
2004
2785
0.050
 Why?
Consensus
1
2023
537
0.050
 Why?
Antibodies, Antinuclear
1
2001
58
0.050
 Why?
Atrophy
1
2021
152
0.050
 Why?
Child
5
2016
18412
0.050
 Why?
Antibodies, Viral
1
2023
520
0.040
 Why?
Mobility Limitation
1
2020
60
0.040
 Why?
Interferon-beta
2
2011
79
0.040
 Why?
Lymphocyte Activation
1
2003
1037
0.040
 Why?
Lipids
1
2023
580
0.040
 Why?
Maintenance Chemotherapy
1
2019
22
0.040
 Why?
Induction Chemotherapy
1
2019
56
0.040
 Why?
Cerebral Infarction
1
1998
39
0.040
 Why?
Cell Separation
2
2014
291
0.040
 Why?
Transplantation, Autologous
1
2019
176
0.040
 Why?
HIV Seronegativity
1
1998
24
0.040
 Why?
Genes, myc
1
1998
46
0.040
 Why?
Astrocytoma
1
1998
108
0.040
 Why?
Risk Assessment
1
2006
2968
0.040
 Why?
In Situ Hybridization
1
2018
292
0.040
 Why?
Gene Library
1
1997
114
0.040
 Why?
Breast Neoplasms
1
2008
1862
0.040
 Why?
Gene Rearrangement
1
1998
135
0.040
 Why?
Real-Time Polymerase Chain Reaction
1
2018
313
0.030
 Why?
Syndecan-1
2
2007
27
0.030
 Why?
Mutation
1
2006
3346
0.030
 Why?
Viral Load
1
2018
405
0.030
 Why?
Flow Cytometry
2
2014
1083
0.030
 Why?
Drug Administration Schedule
1
2018
718
0.030
 Why?
Colorado
1
2005
4099
0.030
 Why?
Child, Preschool
3
2016
9114
0.030
 Why?
Polymerase Chain Reaction
1
1998
993
0.030
 Why?
Survival Analysis
1
2018
1211
0.030
 Why?
Health Knowledge, Attitudes, Practice
2
2016
1183
0.030
 Why?
Sequence Analysis, DNA
1
1997
723
0.030
 Why?
Patient Care Team
1
2019
517
0.030
 Why?
Incidence
1
2020
2313
0.030
 Why?
Base Sequence
1
1997
2114
0.030
 Why?
Congresses as Topic
1
2015
195
0.030
 Why?
Propylene Glycols
1
2013
25
0.030
 Why?
Ocular Physiological Phenomena
1
1992
11
0.030
 Why?
Sphingosine
1
2013
33
0.030
 Why?
HLA-DR Antigens
1
2014
219
0.030
 Why?
Mice
2
2023
14869
0.030
 Why?
beta-Galactosidase
1
1992
62
0.030
 Why?
Drug Therapy, Combination
1
2015
951
0.030
 Why?
Quality-Adjusted Life Years
1
2013
101
0.030
 Why?
Markov Chains
1
2013
114
0.030
 Why?
Animals
3
2023
31706
0.030
 Why?
Mice, Inbred DBA
1
1992
174
0.030
 Why?
Haplotypes
1
2014
448
0.030
 Why?
Mental Recall
1
2013
171
0.020
 Why?
Comparative Effectiveness Research
1
2013
130
0.020
 Why?
Organ Specificity
1
1992
268
0.020
 Why?
Depression
2
2011
1134
0.020
 Why?
Reference Values
1
2013
743
0.020
 Why?
Intestine, Small
1
1992
122
0.020
 Why?
CD3 Complex
1
2012
92
0.020
 Why?
Ki-67 Antigen
1
2012
103
0.020
 Why?
Thymus Gland
1
1992
296
0.020
 Why?
Patient Participation
1
2015
359
0.020
 Why?
Mitoxantrone
1
2011
12
0.020
 Why?
Hematologic Tests
1
2011
22
0.020
 Why?
Muscle Stretching Exercises
1
2011
17
0.020
 Why?
Randomized Controlled Trials as Topic
2
2006
1214
0.020
 Why?
Clinical Laboratory Techniques
1
2011
87
0.020
 Why?
Aged, 80 and over
2
2016
6347
0.020
 Why?
Recombinant Fusion Proteins
1
1992
616
0.020
 Why?
Physical Endurance
1
2011
232
0.020
 Why?
Amino Acid Sequence
2
2004
1982
0.020
 Why?
Prevalence
1
2016
2251
0.020
 Why?
Spinal Cord Neoplasms
1
1989
37
0.020
 Why?
Respiratory Function Tests
1
2011
522
0.020
 Why?
Acyclovir
1
2010
100
0.020
 Why?
Cell Count
1
2010
303
0.020
 Why?
History, 19th Century
1
2009
54
0.020
 Why?
Pilot Projects
2
2004
1373
0.020
 Why?
Neoplasms, Multiple Primary
1
1989
52
0.020
 Why?
Injections
1
2009
159
0.020
 Why?
History, 21st Century
1
2009
159
0.020
 Why?
Autoimmunity
1
2014
813
0.020
 Why?
Electrocardiography
1
2011
560
0.020
 Why?
History, 20th Century
1
2009
264
0.020
 Why?
Mice, Transgenic
1
1992
1949
0.020
 Why?
Gene Expression
1
1992
1421
0.020
 Why?
Age of Onset
1
2009
446
0.020
 Why?
Memory
1
2009
211
0.020
 Why?
Walking
1
2011
422
0.020
 Why?
CD8-Positive T-Lymphocytes
1
2012
687
0.020
 Why?
Health
1
2007
74
0.020
 Why?
Prognosis
2
2006
3329
0.020
 Why?
Association Learning
1
2007
60
0.020
 Why?
Cerebral Ventricles
1
2006
47
0.020
 Why?
Phenotype
1
2014
2796
0.020
 Why?
Hospitalization
1
2015
1752
0.020
 Why?
Motor Skills
1
2007
82
0.020
 Why?
Herpesvirus 3, Human
1
2010
378
0.020
 Why?
Immunologic Memory
1
2007
313
0.020
 Why?
Hypothalamus
1
2006
147
0.020
 Why?
Social Support
1
2009
528
0.020
 Why?
Genetics
1
2005
27
0.020
 Why?
Models, Theoretical
1
2009
515
0.020
 Why?
Neurosciences
1
2005
20
0.020
 Why?
Image Interpretation, Computer-Assisted
1
2006
223
0.010
 Why?
Internet
1
2009
596
0.010
 Why?
Clinical Protocols
1
2006
233
0.010
 Why?
Syndecans
1
2004
5
0.010
 Why?
Anisotropy
1
2004
61
0.010
 Why?
Risk Factors
2
2008
8632
0.010
 Why?
Antiviral Agents
1
2010
645
0.010
 Why?
Plasma Cells
1
2004
56
0.010
 Why?
Immune System
1
2005
172
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Light Chain
1
2003
4
0.010
 Why?
Gene Rearrangement, B-Lymphocyte, Heavy Chain
1
2003
12
0.010
 Why?
Videotape Recording
1
2003
30
0.010
 Why?
Infrared Rays
1
2003
20
0.010
 Why?
Feasibility Studies
1
2006
740
0.010
 Why?
Meningitis, Viral
1
2003
21
0.010
 Why?
Lymphoma, Large B-Cell, Diffuse
1
2005
98
0.010
 Why?
Saccades
1
2003
35
0.010
 Why?
Mice, Inbred C57BL
1
1992
4694
0.010
 Why?
Astrocytes
1
2005
162
0.010
 Why?
Antilymphocyte Serum
1
2003
60
0.010
 Why?
Oligoclonal Bands
1
2003
21
0.010
 Why?
Microglia
1
2005
202
0.010
 Why?
Antigens, CD34
1
2003
89
0.010
 Why?
Clone Cells
1
2003
247
0.010
 Why?
Whole-Body Irradiation
1
2003
73
0.010
 Why?
Receptors, Antigen, B-Cell
1
2003
107
0.010
 Why?
Immunoglobulins
1
2003
143
0.010
 Why?
Tomography, X-Ray Computed
1
2012
2285
0.010
 Why?
Observer Variation
1
2003
295
0.010
 Why?
Longitudinal Studies
1
2009
2387
0.010
 Why?
Sex Characteristics
1
2007
640
0.010
 Why?
Age Factors
1
2009
2894
0.010
 Why?
Infant
1
2015
7961
0.010
 Why?
Administration, Oral
1
2004
728
0.010
 Why?
Urinary Tract Infections
1
2003
134
0.010
 Why?
Cohort Studies
1
2011
4895
0.010
 Why?
Biopsy
1
2005
1036
0.010
 Why?
Reverse Transcriptase Polymerase Chain Reaction
1
2003
923
0.010
 Why?
Predictive Value of Tests
1
2006
1796
0.010
 Why?
Immunoglobulin kappa-Chains
1
2001
18
0.010
 Why?
Cytomegalovirus Infections
1
2003
180
0.010
 Why?
Acute Disease
1
2003
911
0.010
 Why?
Immunoglobulin Fab Fragments
1
2001
69
0.010
 Why?
Lung
1
1992
3561
0.010
 Why?
Combined Modality Therapy
1
2003
1121
0.010
 Why?
Research
1
2003
394
0.010
 Why?
Survival Rate
1
2003
1644
0.010
 Why?
Sensitivity and Specificity
1
2003
1692
0.010
 Why?
Arachnoid
1
1998
9
0.010
 Why?
Models, Biological
1
2005
1620
0.010
 Why?
Case-Control Studies
1
2004
3003
0.010
 Why?
Aging
1
2007
1618
0.010
 Why?
Reproducibility of Results
1
2003
2763
0.010
 Why?
Corboy's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
See all (369) concept(s)
_
Co-Authors Expand Description
See all (34) people
_
Similar People Expand Description
See all (60) people
_
Same Department Expand Description
Search Department
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)